Friday, July 15, 2022 9:03:59 AM
Press Release | 07/15/2022
ESTERO, Fla., July 15, 2022 (GLOBE NEWSWIRE) -- Marijuana Strategic Ventures, Inc. (the “Company”) (OTC: MSVI) announces updates to the progress of its three areas of focus: Health, Innovation and Research & Development.
In Health, the Company has secured sourcing for the 4 Telogenix products currently listed on the website, www.mushroomsinc.com, as well as 2 additional products: one specific to athletes and another for removal of plaque from the arteries. All the ingredients are certified organic, non-GMO, gluten free and fair trade. The capsules for each product will be made and packaged in California. We are working towards the goal of product availability at the end of September. We are simultaneously working on product placement in organic focused, health-oriented stores as well as online.
For Innovation, we have begun to build the MYCO Experience team. We are currently looking at California for the location of the first MYCO Experience event and have 2023 as the projected year for the inaugural launch event. Social media for Mushrooms Inc. is guided by the MYCO Experience creative team. They are working on a monthly video format to educate about the world of mushrooms, connect that knowledge to innovation and grow an awareness and enthusiasm for this rapidly growing market. The 2023 MYCO Experience event looks to be the touch, taste and feel of the industry, as an Expo would be if it was integrated with beautiful live art and nature.
In Research and Development, we have made significant progress in filing our first provisional patent. We believe our new process will have end benefits in the medical industry while using green industrial waste as part of its composition. Outside the medical industry, we have aimed our end products to prolong the carbon hold of green waste through the creation of products with longevity of use. Rather than farmers burning the waste in fields, thus releasing the carbon it sequestered back into the atmosphere, we will repurpose the waste into green products and hold the carbon capture with credit valuation applied. When the product life cycle reaches its end, we are looking for results of quick, non-toxic decomposition in comparison to the current products in the market that we work to replace.
Kimberly Carlson, CEO of Mushrooms, Inc., commented, “I am working with a small and passionate team to create a 5-year business plan focused on bringing value to shareholders. I am excited about the current momentum as the major parts are coming together into a steady foundation of interconnected resources and creative passion.”
MSVI is also excited that the U.S. House of Representatives on Wednesday (July 13th) approved a bipartisan pair of psychedelics research amendments, as well as another measure requiring a military study into marijuana-related enforcement discrimination in the armed services. See the following article here for more details.
Recent MSRM News
- Mushrooms Inc. (OTC:MSRM) Launches New Health Supplements, Progresses with German Partnership, and Boosts Engagement Initiatives. • InvestorsHub NewsWire • 03/05/2024 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/08/2024 02:55:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 05:18:40 PM
- Mushrooms Inc (OTC:MSRM) Announces Full Patent Filing for Groundbreaking Mycelium Technology Providing Bacterial Detection and Nutrient Delivery. • InvestorsHub NewsWire • 10/18/2023 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/14/2023 02:27:19 PM
- Mushrooms, Inc. (OTC: MSRM) Announces Diverse Business Development Team Assembled to Drive Company Growth. • InvestorsHub NewsWire • 08/23/2023 01:00:00 PM
- Mushrooms, Inc. (OTC: MSRM) is Poised for Textile Innovation and Global Impact as Full Patent Filing for Mycelium Thread Nears Completion. • InvestorsHub NewsWire • 08/08/2023 12:00:00 PM
- Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast. • InvestorsHub NewsWire • 07/19/2023 12:32:27 PM
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM